- Report
- May 2025
- 350 Pages
Global
From €3587EUR$3,995USD£3,055GBP
- Report
- May 2025
- 650 Pages
Global
From €3587EUR$3,995USD£3,055GBP
- Report
- June 2025
- 681 Pages
Global
From €6281EUR$6,995USD£5,348GBP
- Report
- March 2025
- 585 Pages
Global
From €6281EUR$6,995USD£5,348GBP
- Report
- September 2024
- 106 Pages
Global
From €4938EUR$5,500USD£4,205GBP
- Report
- May 2025
- 181 Pages
Global
From €3183EUR$3,545USD£2,711GBP
€3537EUR$3,939USD£3,012GBP
- Report
- May 2025
- 180 Pages
Global
From €3183EUR$3,545USD£2,711GBP
€3537EUR$3,939USD£3,012GBP
- Report
- May 2025
- 193 Pages
Global
From €3183EUR$3,545USD£2,711GBP
€3537EUR$3,939USD£3,012GBP
- Report
- May 2025
- 184 Pages
Global
From €3183EUR$3,545USD£2,711GBP
€3537EUR$3,939USD£3,012GBP
- Report
- May 2025
- 183 Pages
Global
From €3183EUR$3,545USD£2,711GBP
€3537EUR$3,939USD£3,012GBP
- Report
- May 2025
- 184 Pages
Global
From €3183EUR$3,545USD£2,711GBP
€3537EUR$3,939USD£3,012GBP
- Report
- May 2025
- 195 Pages
Global
From €3183EUR$3,545USD£2,711GBP
€3537EUR$3,939USD£3,012GBP
- Report
- May 2025
- 193 Pages
Global
From €3183EUR$3,545USD£2,711GBP
€3537EUR$3,939USD£3,012GBP
- Report
- March 2025
- 180 Pages
Global
From €5342EUR$5,950USD£4,549GBP
- Report
- June 2024
- 180 Pages
Global
From €5342EUR$5,950USD£4,549GBP
- Report
- March 2025
- 200 Pages
Global
From €4031EUR$4,490USD£3,433GBP
- Report
- February 2025
- 200 Pages
Global
From €4031EUR$4,490USD£3,433GBP
- Report
- February 2025
- 200 Pages
Global
From €4031EUR$4,490USD£3,433GBP
- Report
- June 2025
- 73 Pages
Global
From €5252EUR$5,850USD£4,473GBP
- Report
- June 2025
- 208 Pages
Global
From €5252EUR$5,850USD£4,473GBP

The Genomic Medicine market is a rapidly growing sector of the genomics industry. It focuses on the development and application of genomic technologies to improve healthcare outcomes. This includes the use of genomic sequencing to diagnose and treat diseases, as well as the development of personalized treatments based on a patient's genetic profile. Genomic Medicine also involves the use of bioinformatics to analyze and interpret genomic data, and the development of new technologies to enable the use of genomic data in clinical practice.
The Genomic Medicine market is driven by the increasing availability of genomic data, advances in sequencing technologies, and the growing demand for personalized healthcare. It is expected to continue to grow in the coming years, as more healthcare providers adopt genomic technologies and the use of genomic data becomes more widespread.
Some companies in the Genomic Medicine market include Illumina, Thermo Fisher Scientific, BGI, and Pacific Biosciences. Show Less Read more